Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances
Intraocular malignant tumors are rare; however, they can cause serious life-threatening complications. Uveal melanoma (UM) and retinoblastoma (RB) are the most common intraocular tumors in adults and children, respectively, and come with a great disease burden. For many years, several different trea...
Saved in:
Main Authors: | Merve Kulbay, Nicolas Tuli, Massimo Mazza, Armaan Jaffer, Sarinee Juntipwong, Emily Marcotte, Stuti Misty Tanya, Anne Xuan-Lan Nguyen, Miguel N. Burnier, Hakan Demirci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/108 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
by: Michele Massimino, et al.
Published: (2025-01-01) -
Spatially resolved transcriptomics reveals gene expression characteristics in uveal melanoma
by: Jing-Ying Xiu, et al.
Published: (2025-01-01) -
Co-isolation of human donor eye cells and development of oncogene-mutated melanocytes to study uveal melanoma
by: Yunxi Chen, et al.
Published: (2025-01-01) -
Identification of new candidate genes for the hereditary predisposition to uveal melanoma: IGCMU trial
by: Mélanie Godiveau, et al.
Published: (2025-01-01) -
Single-cell RNA sequencing and AlphaFold 3 insights into cytokine signaling and its role in uveal melanoma
by: Hongyan Sun, et al.
Published: (2025-01-01)